Seung Cheol Ha1, Jungsu S Oh2, Jong-Lyel Roh3, Hyojeong Moon2, Jae Seung Kim2, Kyung-Ja Cho4, Seung-Ho Choi1, Soon Yuhl Nam1, Sang Yoon Kim1. 1. Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. 2. Departments of Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea. 3. Departments of Otolaryngology, Asan Medical Center, University of Ulsan College of Medicine, 88 Olympic-ro 43-gil, Songpa-gu, Seoul, 05505, Republic of Korea. rohjl@amc.seoul.kr. 4. Departments of Pathology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
Abstract
PURPOSE: Head and neck soft tissue sarcoma (HNSTS) is a rare type of tumor with various histological presentations and clinical behaviors. 18F-FDG PET/CT is being increasingly used for staging, grading, and predicting treatment outcomes in various types of human cancers, although this modality has been rarely studied in the survival prediction of HNSTS. Here we examined the prognostic value of tumor metabolic parameters measured using 18F-FDG PET/CT in patients with HNSTS. METHODS: This study included 36 consecutive patients with HNSTS who underwent 18F-FDG PET/CT scanning prior to treatment at our institution. Tumor gross total volume (GTV) was measured from pretreatment contrast-enhanced CT scans, and maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured using pretreatment 18F-FDG PET/CT scans. Univariate and multivariate Cox proportional hazard regression analyses were used to identify associations between imaging parameters and disease-specific survival (DSS) or overall survival (OS). RESULTS: Univariate analyses showed that SUVmax, MTV, and TLG, but not GTV, were significantly associated with DSS and OS (all P < 0.05). After controlling for clinicopathological factors, SUVmax, MTV, and TLG were significantly associated with DSS and OS (all P < 0.05). Patients with a tumor SUVmax value of >7.0 experienced an approximately fivefold increase in mortality in terms of DSS and OS relative to those with a tumor SUVmax <7.0. CONCLUSION: Quantitative metabolic measurements on pretreatment 18F-FDG PET/CT can yield values that are significantly predictive of survival after treatment for HNSTS.
PURPOSE: Head and neck soft tissue sarcoma (HNSTS) is a rare type of tumor with various histological presentations and clinical behaviors. 18F-FDG PET/CT is being increasingly used for staging, grading, and predicting treatment outcomes in various types of humancancers, although this modality has been rarely studied in the survival prediction of HNSTS. Here we examined the prognostic value of tumor metabolic parameters measured using 18F-FDG PET/CT in patients with HNSTS. METHODS: This study included 36 consecutive patients with HNSTS who underwent 18F-FDG PET/CT scanning prior to treatment at our institution. Tumor gross total volume (GTV) was measured from pretreatment contrast-enhanced CT scans, and maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) were measured using pretreatment 18F-FDG PET/CT scans. Univariate and multivariate Cox proportional hazard regression analyses were used to identify associations between imaging parameters and disease-specific survival (DSS) or overall survival (OS). RESULTS: Univariate analyses showed that SUVmax, MTV, and TLG, but not GTV, were significantly associated with DSS and OS (all P < 0.05). After controlling for clinicopathological factors, SUVmax, MTV, and TLG were significantly associated with DSS and OS (all P < 0.05). Patients with a tumor SUVmax value of >7.0 experienced an approximately fivefold increase in mortality in terms of DSS and OS relative to those with a tumor SUVmax <7.0. CONCLUSION: Quantitative metabolic measurements on pretreatment 18F-FDG PET/CT can yield values that are significantly predictive of survival after treatment for HNSTS.
Entities:
Keywords:
18F-FDG PET/CT; Head and neck soft tissue sarcoma; Metabolic volume; Prognosis; Standardized uptake value
Authors: Susie A Chen; Christopher G Morris; Robert J Amdur; John W Werning; Douglas B Villaret; William M Mendenhall Journal: Am J Clin Oncol Date: 2005-06 Impact factor: 2.339
Authors: Q T Le; K K Fu; S Kroll; L Fitts; V Massullo; L Ferrell; M J Kaplan; T L Phillips Journal: Int J Radiat Oncol Biol Phys Date: 1997-03-15 Impact factor: 7.038
Authors: Wolfgang P Fendler; Rebecca P Chalkidis; Harun Ilhan; Thomas Knösel; Ken Herrmann; Rolf D Issels; Peter Bartenstein; Clemens C Cyran; Lars H Lindner; Marcus Hacker Journal: Eur Radiol Date: 2015-02-19 Impact factor: 5.315
Authors: Max Lonneux; Marc Hamoir; Hervé Reychler; Philippe Maingon; Christian Duvillard; Gilles Calais; Boumédiène Bridji; Laurence Digue; Michel Toubeau; Vincent Grégoire Journal: J Clin Oncol Date: 2010-02-01 Impact factor: 44.544
Authors: Brandon G Bentz; Bhuvanesh Singh; James Woodruff; Murray Brennan; Jatin P Shah; Dennis Kraus Journal: Ann Surg Oncol Date: 2004-06 Impact factor: 5.344
Authors: Amani Arthur; Edward W Johnston; Jessica M Winfield; Matthew D Blackledge; Robin L Jones; Paul H Huang; Christina Messiou Journal: Front Oncol Date: 2022-07-01 Impact factor: 5.738
Authors: Turki M Almuhaimid; Won Sub Lim; Jong-Lyel Roh; Jungsu S Oh; Jae Seung Kim; Soo-Jong Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim Journal: J Cancer Res Clin Oncol Date: 2018-10-06 Impact factor: 4.553
Authors: Sun Young Chae; Seol Hoon Park; Hyo Sang Lee; Jin-Hee Ahn; Sung-Bae Kim; Kyung Hae Jung; Jeong Eun Kim; Sei Hyun Ahn; Byung Ho Son; Jong Won Lee; Beom Seok Ko; Hee Jeong Kim; Gyungyub Gong; Jungsu S Oh; Seo Young Park; Dae Hyuk Moon Journal: Sci Rep Date: 2022-05-12 Impact factor: 4.996